Rikki Bannan - Don't get caught up in momentum, remain skeptical, be clear on your thesis | Summer Series
Dec 18, 2024
auto_awesome
Rikki Bannan, the Executive Director of Small Caps at IFM Investors, shares her expertise in biotech investing, discussing standout stocks like Telix and Clarity that have soared in 2024. She emphasizes the importance of skepticism in investing and staying true to your thesis. Rikki also reveals three key lessons from her career, including the need for thorough research and understanding intrinsic value. This conversation is a treasure trove for young investors, exploring the dynamics of small-cap stocks and the art of effective portfolio management.
Rikki Bannon emphasizes the importance of developing a clear investment thesis and maintaining skepticism to navigate market volatility effectively.
She highlights successful small cap investments like Telix and Clarity, showcasing the potential for significant returns through rigorous analysis and portfolio diversification.
Deep dives
Gold Belly: A Unique Gift Idea
Gold Belly is an innovative platform that delivers iconic foods from famous restaurants across the United States directly to customers' doors. Offering a diverse range of culinary delights, it includes items such as Chicago deep dish pizza, New York bagels, and Maine lobster rolls, making it a perfect gift for food enthusiasts. This service effectively bridges the gap between geography and gastronomic experiences, allowing people to enjoy regional specialties regardless of their location. Additionally, first-time buyers can benefit from a 20% discount using the promotional code GIFT.
Investment Insights with Rikki Bannon
Rikki Bannon, an executive director at IFM Investors and a recognized stock picker, shares her investment strategies and insights during her discussion on small caps. Notably, she highlights her successful pitches, such as Tealix and Clarity Pharmaceuticals, both of which have seen significant returns, emphasizing the potential for high growth within the small cap sector. Bannon underscores the importance of careful portfolio construction, especially when investing in high-risk areas like biotech. Her approach combines rigorous analysis with a focus on developing a sound thesis for each investment, enabling her to manage risk while capturing growth.
The Role of Macroeconomic Factors
The discussion includes the impact of macroeconomic trends on investment strategies, particularly in relation to interest rates and their influence on various sectors. Investors are paying close attention to potential Federal Reserve actions and their implications for markets, weighing opportunities in leveraged financial instruments like tech stocks and REITs. Bannon points out that current market dynamics have led to a renewed interest in how falling rates could benefit certain industries and hints at the potential for a soft landing in the economy. This context informs her investment decisions, especially when evaluating stocks with significant exposure to these economic factors.
Understanding Volatility and Risk in Investing
Bannon emphasizes the distinction between volatility and risk, arguing that volatility should not be conflated with a permanent loss of capital. She explains that while price fluctuations can create uncertainty, they also provide valuable opportunities for savvy investors. Maintaining a healthy skepticism and using independent analysis are crucial components of her investment philosophy. By developing a deep understanding of the companies they invest in and recognizing the potential for short-term price movements, investors can make informed decisions that align with their financial goals.
Rikki Bannan is the Executive Director, Small Caps at IFM Investors.
Throughout this Summer Series, we're speaking to 12 accomplished investors and financial advisors to unpack their journeys in finance and the lessons they've learned along the way.
In today's conversation with Rikki, we're unpacking:
The investing opportunities Rikki is exploring today
3 key lessons from her career that have stuck with Rikki
How Rikki found biotech winners like Telix (up 150% in 2024) and Clarity (up 180% in 2024)
How these biotech names can fit in a diversified portfolio
What Rikki wishes she could teach every young investor
—------
Thank you to Viola Private Wealth for sponsoring this Summer Series and helping us keep all of our content free.
With $2.5 billion under management, Viola Private Wealth provides tailored solutions for high-net-worth investors. Their boutique firm specialises in helping individuals and families navigate the complexities of wealth management with clarity and confidence.
In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today.
—------
Equity Mates Investing is a product of Equity Mates Media.
This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional.
Equity Mates Media operates under Australian Financial Services Licence 540697.